An Updated Review on the Secondary Metabolites and Biological Activities of <i>Aspergillus ruber</i> and <i>Aspergillus flavus</i> and Exploring the Cytotoxic Potential of Their Isolated Compounds Using Virtual Screening

<div>2D and 3D binding mode of 1,6,8-trihydroxy-4-benzoyloxy-3-methylanthraquinone (23) in the active center of human cyclin-dependent kinase 2 (CDK-2) (a), variecolorin H (14) in the active center of DNA topoisomerase II (TOP-2) (b), and 1,6,8-trihydroxy-4-benzoyloxy-3 methylanthraquinone (23) in the active center of matrix metalloprotinase 13 (MMP-13) (c) active centers using C-docker protocol.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: An Updated Review on the Secondary Metabolites and Biological Activities of <i>Aspergillus ruber</i> and <i>Aspergillus flavus</i> and Exploring the Cytotoxic Potential of Their Isolated Compounds Using Virtual Screening 

Figure 4 | An Updated Review on the Secondary Metabolites and Biological Activities of Aspergillus ruber and Aspergillus flavus and Exploring the Cytotoxic Potential of Their Isolated Compounds Using Virtual Screening 